NCT01900041 - A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions

Female Pattern Hair LossAndrogenetic Alopecia (AGA)Ludwig Type 1Ludwig Type 2

Interventions

DRUG

Pantovigar

1 capsule of Pantovigar for oral intake, given three times a day. Duration of treatment: 6 months.

DRUG

Minoxidil 2% only

1 ML of Minoxidil 2% solution twice a day applied to the scalp. Duration of treatment: 6 months.

Trial Locations (2)

State Scientific Center of Dermatology and Cosmetology, Moscow

Moscow Scientific Clinical Center of Dermatology and Cosmetology, Moscow